Heinrich T, Nanda I, Rehn M, et al. Live-born Trisomy 22: patient report and review[J]. Mol Syndromol, 2013, 3(6): 262-269.
[2]
Voiculescu I, Back E, Duncan AM, et al. Trisomy 22 in a newborn with multiple malformations[J]. Hum Genet, 1987, 76(3): 298-301.
[26]
Person AD, Garriock RJ, Krieg PA, et al. Frzb modulates Wnt-9a-mediated beta-catenin signaling during avian atrioventricular cardiac cushion development[J]. Dev Biol, 2005, 278(1): 35-48.
[3]
Crowe CA, Schwartz S, Black CJ, et al. Mosaic trisomy 22: a case presentation and literature review of trisomy 22 phenotypes[J]. Am J Med Genet, 1997, 71(4): 406-413.
3.0.CO;2-R target="_blank">
[27]
Cai X, Zhang W, Hu J, et al. Tbx20 acts upstream of Wnt signaling to regulate endocardial cushion formation and valve remodeling during mouse cardiogenesis[J]. Development, 2013, 140(15): 3176-3187.
[4]
Tinkle BT, Walker ME, Blough-Pfau RI, et al. Unexpected survival in a case of prenatally diagnosed non-mosaic trisomy 22: Clinical report and review of the natural history[J]. Am J Med Genet A, 2003, 118A(1): 90-95.
Kruithof BP, Krawitz SA, Gaussin V. Atrioventricular valve development during late embryonic and postnatal stages involves condensation and extracellular matrix remodeling[J]. Dev Biol, 2007, 302(1): 208-217.
[29]
Freeman RV, Otto CM. Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies[J]. Circulation, 2005, 111(24): 3316-3326.
[7]
Hall T, Samuel M, Brain J. Mosaic trisomy 22 associated with total colonic aganglionosis and malrotation[J]. J Pediatr Surg, 2009, 44(1): e9-e11.